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Abstract
Background: DNA microarrays open up a new horizon for studying the genetic determinants of
disease. The high throughput nature of these arrays creates an enormous wealth of information,
but also poses a challenge to data analysis. Inferential problems become even more pronounced as
experimental designs used to collect data become more complex. An important example is
multigroup data collected over different experimental groups, such as data collected from distinct
stages of a disease process. We have developed a method specifically addressing these issues
termed Bayesian ANOVA for microarrays (BAM). The BAM approach uses a special inferential
regularization known as spike-and-slab shrinkage that provides an optimal balance between total
false detections and total false non-detections. This translates into more reproducible differential
calls. Spike and slab shrinkage is a form of regularization achieved by using information across all
genes and groups simultaneously.
Results: BAMarray™ is a graphically oriented Java-based software package that implements the
BAM method for detecting differentially expressing genes in multigroup microarray experiments
(up to 256 experimental groups can be analyzed). Drop-down menus allow the user to easily select
between different models and to choose various run options. BAMarray™ can also be operated in
a fully automated mode with preselected run options. Tuning parameters have been preset at
theoretically optimal values freeing the user from such specifications. BAMarray™ provides
estimates for gene differential effects and automatically estimates data adaptive, optimal cutoff
values for classifying genes into biological patterns of differential activity across experimental
groups. A graphical suite is a core feature of the product and includes diagnostic plots for assessing
model assumptions and interactive plots that enable tracking of prespecified gene lists to study such
things as biological pathway perturbations. The user can zoom in and lasso genes of interest that
can then be saved for downstream analyses.
Conclusion: BAMarray™ is user friendly platform independent software that effectively and
efficiently implements the BAM methodology. Classifying patterns of differential activity is greatly
facilitated by a data adaptive cutoff rule and a graphical suite. BAMarray™ is licensed software freely
available to academic institutions. More information can be found at http://www.bamarray.com.
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Background
DNA microarray technology allows researchers to esti-
mate the relative expression levels of thousands of genes
simultaneously over different time points, different exper-
imental conditions, or different tissue samples. It is the
relevant abundance of the mRNA genetic product that
provides surrogate information about the relative abun-
dance of the cell's proteins. The differences in protein
abundance are what characterize phenotypic differences
between cells. Identifying such differences (even at the
mRNA level) can lead to insight about biological proc-
esses and pathways that might be involved in a disease
process as well as highlight new potential targets for diag-
nostic and therapeutic development. See [1-4] for more
background on microarrays.
Identifying signal in the presence of abundant noise
While potentially rich in information, microarray data
pose a serious statistical challenge due to the sheer vol-
ume of information being processed [5]. It is the norm to
see data collected on tens of thousands of genes from only
a handful of samples. Data analysis is further complicated
because of heterogeneity of gene-specific variances and
correlation of gene expressions due to biological effect or
technological artifact. Although many inferential ques-
tions are of interest, a common concern is of the detection
of differentially expressing genes between experimental
groups (e.g., between control samples and treatment sam-
ples, or between normal tissue samples and diseased tis-
sue samples). Because of the large number of genes and
tests involved, and because of the many inherent sources
of noise in microarray data, the potential for Type-I errors
or false detections is large. For two-group problems, a
common strategy is to control the false discovery rate
(FDR) using the method of [6] or empirical Bayes meth-
ods [7-9]. However, while these methods work well in
controlling FDR, the price paid is often a conservativeness
that leads to missing important genes [10]. Indeed, in
two-group problems, the total number of misclassified
genes can be derived in closed form assuming normally
distributed data [11]. Such calculations suggest that when
the fraction of truly differentially expressing genes is rela-
tively low, total misclassification of differential effects will
be large unless FDR is controlled at a high value, thus
putting into question the value of such control.
Multigroup data
The issues become more complex for multigroup data col-
lected over different experimental groups, such as data
collected from distinct stages of a disease process, or time
course experiments in which microarrays are used to track
gene expression profiles over time (the time points can be
thought of as groups). The richness of such data lends
itself to a myriad of potential questions and each question
brings with it the thorny statistical problems associated
with multiple testing. Because of this, most approaches
start by simplifying multigroup hypotheses into a com-
posite question that can be tested using a one-dimen-
sional test statistic for each gene. While this is certainly
convenient – for example, it makes it possible to apply
standard error control methods such as the FDR – the
strategy may not be optimal for several reasons. First, the
underlying test statistic is likely to be fairly elementary,
and thus highly variable because it will not be regularized.
That is, the test is not likely to be constructed in a way that
uses information across all genes and samples. Regulariza-
tion is an important concept in microarray settings where
sample sizes are small and the number of parameters are
large (we will say more on this shortly). Secondly, com-
posite statistics are seriously limited in the information
they provide. Consider an F-test analysis involving con-
trasts for identifying specific patterns of differential
expression across groups. For example, consider a gene
that differentially expresses early on in a disease process,
such as cancer, significantly affecting the biological milieu
and making it possible for other genes to act, but then
later vanishes. We call this a hit-and-run hypothesis. A con-
trast, or set of contrasts, looking for hit-and-run genes
would simply provide what is equivalent to a p-value for
rejecting the null hypothesis of no such pattern being
present, but it would tell you very little about the likeli-
hood of classifying a gene as having a hit-and-run pattern
as apposed to some other pattern type.
Rescaled spike and slab model selection and regularization
Recently Ishwaran and Rao [12], building upon work in
[10], introduced a method for detecting differentially
expressing genes between multiple groups termed Baye-
sian ANOVA for microarrays (BAM). This method recasts
the statistical problem as a high dimensional model selec-
tion problem, and uses a specific Bayesian hierarchical
model oriented towards adaptive shrinkage. By using
model averaging, a way of accounting for model uncer-
tainty, BAM provides gene effect estimates that are
shrunken relative to standard least square estimates in
which primarily only the non-differentially expressing
gene effects are shrunken. This is a general phenomenon
called selective shrinkage [12,13] that enables BAM to opti-
mally balance total false detections (the total number of
genes falsely identified as being differentially expressed)
against total false non-detections (the total number of
genes falsely identified as being non-differentially
expressed). Selective shrinkage, theoretically, translates
into more reproducible differential calls. BAM's ability to
selectively shrink gene effects is an important form of reg-
ularization and is due to the use of a rescaled spike and
slab model introduced by [13]. This model, in combina-
tion with a carefully selected continuous bimodal prior
(also introduced in [13]), enables BAM to use data across
all genes and all experimental groups to accurately esti-BMC Bioinformatics 2006, 7:59 http://www.biomedcentral.com/1471-2105/7/59
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mate different levels of sparsity (the percentage of genes
differentially expressing over a specific experimental
group) and then to selectively shrink gene effects based on
the estimated complexities. Equivalently, this procedure
can be viewed as a penalization method in which each
gene effect has a unique penalty term that is adaptively
estimated from the data [12].
The BAM estimation procedure is fully automatic and is
based on a Gibbs sampling algorithm. Not only are regu-
larized differential gene effects estimated, but so is an
automatic data adaptive cutoff value for determining which
genes are differentially expressing. This cutoff value, for
large enough sample sizes, has the theoretical property of
delineating genes with true differential expression from
those genes with no differential activity [12]. This is cru-
cial, since determining an appropriate cutoff value is a
critical aspect in searching for differential expression
(whatever the method being used).
Another important feature in analyzing microarray data is
the ability to systematically deal with heterogeneity of var-
iances across genes and groups. Variance stabilization can
lead to tremendous gains in power and is another impor-
tant aspect of regularization. This issue was discussed in
depth in [10,12] and Ishwaran and Papana (2005).
BAMarray™ incorporates a nonparametric Classification
and Regression Tree (CART) clustering algorithm
described in Ishwaran and Papana (2005) to effectively
deal with unequal variances. Of note is that the procedure
does not artificially dampen or amplify group differences
across genes for the sake of attaining variance stabiliza-
tion.
Illustrative example: tracking the genomic stagewise 
development of liver metastatic colon cancer
As preliminary illustration and motivation for BAMar-
ray™, we look at expression data from a large microarray
repository of colon cancer tissue samples comprising var-
ious stages of tumor progression. This data were obtained
from Sanford Markowitz at the Ireland Cancer Center of
Case Western Reserve University. All gene expression data
were collected using high density 59K-on-one gene chips
developed by EOS Biotechnology. These are Affymetrix-
derived chips with proprietary probe sets. The high den-
sity of probe sets reflects known genes and ESTs
(expressed sequence tags) as well as predicted exons.
Figure 1 shows a BAMarray™ analysis of the data using
four distinct tissue samples: Duke's B, C, D and liver METS
(the figure is produced as part of the graphical suite avail-
able in BAMarray™). The Duke's B samples represent Duke
BSurvivors comprising patients still alive from the time of
initial diagnosis. These represent an intermediate stage of
cancer and form our control (baseline) group. We would
like to track changes in gene expression across the stages
of disease relative to this baseline. Duke's C samples rep-
Standard ANOVA Z-test statistics (reproduced from [12]) Figure 2
Standard ANOVA Z-test statistics (reproduced from 
[12]). Arrows indicate quadrants containing potential hit-
and-run genes using 95% confidence regions. Note the 
excess noise.
Zcut values from the colon cancer analysis Figure 1
Zcut values from the colon cancer analysis. Vertical 
and horizontal axes are Zcut values measuring difference 
between D's versus BSurvivors and METS versus BSurvivors, 
respectively. Genes differentially expressing for both groups 
(magenta); D's but not METS (green); METS but not D's 
(blue); none (black). C versus BSurvivors differentially 
expressed genes are indicated by ∆ (turning on) and ∇ (turn-
ing off).BMC Bioinformatics 2006, 7:59 http://www.biomedcentral.com/1471-2105/7/59
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resent a progressive worsening of the disease as the cancer
begins to invade deeper into the colon wall and spread to
nearby lymph nodes. The liver METS (METS) represent
metastatic disease to the liver from the original primary
tumor. The Duke's D samples represent the deposit left
over in the colon after liver metastasis. Plotted in Figure 1
are BAM estimated gene differential effects (with respect
to the BSurvivors) we call Zcut values. One can think of
these as Bayesian test statistics. Figure 1 plots Zcut values
for the METS and D's on the x and y axes respectively. Also
overlayed on the plot are triangles for identifying genes
turning off or on for stage C relative to the BSurvivors. The
figure uses color to highlight stagewise gene effects of bio-
logic interest. Points colored in magenta are genes with
significant differential expression across the D's and
METS. These are genes either being turned on or turned off
relative to the BSurvivors. For example the small cluster of
magenta triangles in the bottom-left quadrant indicate
genes that turn off throughout the C, D and METS sam-
ples. Data points colored in green and blue indicate genes
that are significant (in either direction) for only the stage
D's but not the METS or only for the METS and not the
stage D's, respectively. In particular, green points that hug
the  y-axis are those genes showing significant changes
from BSurvivors to D's but whose METS expression resem-
ble the BSurvivors. These are sometimes termed (early)
hit-and-run genes because they differentially express early
on in the disease progression, potentially significantly
altering the biological milieu making it possible for other
genes to act, but then later vanish in terms of biological
effect. Note that statistical cutoffs used for identifying dif-
ferentially expressing genes here have all been adaptively
estimated.
Standard least square test statistics (Z-tests) from a tradi-
tional ANOVA models provide a strikingly different plot.
Figure 2 plots these values. Especially apparent is the ellip-
soid nature of the figure. As was shown in [12], this is due
to the high variability of the estimates and because of a
regression to the mean effect caused by the correlation
between the Z-statistics, in this case for METS versus BSur-
vivors and D versus BSurvivors genewise effect estimates.
Regression to the mean inflates false detections and makes
it more difficult to delineate signal from noise. Notice
how difficult it is to identify any hit-and-run candidates.
Early hit-and-run genes might be the ones in the quad-
Brain tissue data Figure 3
Brain tissue data. The first few lines of the brain tissue dataset (ASCII). Data comes bundled with the BAMarray™ install 
package.BMC Bioinformatics 2006, 7:59 http://www.biomedcentral.com/1471-2105/7/59
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rants indicated by the two arrows, but it is not so clear.
This type of effect is strikingly absent in Figure 1 and
clearly shows the benefits of shrinkage.
Implementation
Software architecture
BAMarray™ (Release 2.0) is a stand-alone platform inde-
pendent desktop Java application. Solutions currently
exist for the Mac OS X, Linux, and Windows XP operating
systems. A native code C library is at the core of the prod-
uct. This library implements the BAM algorithm and con-
sists of several components including data pre-processing,
data variance stabilizing transformations, and the Gibbs
sampler. A Java graphical user interface surrounds the
native code library and allows the user to interact with the
library and conduct customized data analysis.
Installing and uninstalling BAMarray™
BAMarray™ is available for download in the form of a self-
extracting executable install package. Details can be found
at http://www.bamarray.com. Users must register online
in order to download the product. A 30-day evaluation
license key will be automatically generated and emailed to
the user upon registration (a full production license key
will be emailed upon completing a signed license agree-
ment). The user may then download the install package
and execute the file according to the operating system spe-
cific protocol. The user completes the install by following
the prompts generated by the package.
On first run, BAMarray™ will query the user for the license
key. Once the key is verified, the product will present the
user with the main console from which analysis can pro-
ceed.
Uninstalling BAMarray™ is as straightforward as the install
process. An uninstall icon is produced during the install
process in the product's home directory. Double-clicking
on this icon will remove the product from the system.
User modified data files will remain, but can be disposed
of manually if so desired.
Some key software features
1. BAMarray is a stand-alone platform independent desk-
top Java application. Solutions currently exist for the Mac
OS X, Linux, and Windows XP operating systems.
Brain tissue data Figure 4
Brain tissue data. The first few lines of the brain tissue dataset (EXCEL). Data comes bundled with the BAMarray™ install 
package.BMC Bioinformatics 2006, 7:59 http://www.biomedcentral.com/1471-2105/7/59
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2. Full multigroup analysis for up to 256 groups can be
handled. Overlay multigroup plots (similar to Figure 1)
are available for visualizing how genes are mapped to spe-
cific pattern types of differential expression across groups.
3. Graphical zoom-in and lassoing tools enable the user to
interactively generate lists of differentially expressing
genes.
4. Gene labels can be toggled on or off allowing genes of
interest to be readily identified. Genes of interest (such as
those making up a biological pathway of interest) can be
highlighted using a selection list.
5. Gene lists of interest can be exported for further explo-
ration.
6. Unequal variances across genes and groups are system-
atically handled by an automated pre-processing step.
Results
Note on normalization of microarray data
BAMarray™ assumes that the data to be analyzed has been
suitably normalized (exact data formats and importing of
data is discussed in subsequent sections). Normalization
is simply the removal of systematic effects across samples
that might bias inference. Two examples are batch effects
in which samples were run, and dates that samples were
extracted. Normalization can significantly affect microar-
ray inferences [14]. The user is required to provide suita-
bly normalized expression data to BAMarray™.
Normalization procedures are currently not provided within
the package, but a future release (3.0) will have this capa-
bility (see the Discussions section for details).
Normalization methods for two-color array data (such as
cDNA arrays) are discussed in [15]. For Affymetrix oligo-
nucleotide arrays, suitable options include the Affymetrix
MAS 5.0 analysis suite [16] or robust multi-array analysis
[17]. These, and other, procedures are available in Biocon-
ductor [18].
Data formats and importing data files
BAMarray™ supports microarray data in the form of an
EXCEL spreadsheet or space-delimited text file (missing
values are however not allowed). The first row of the file
should contain class label information (i.e., the group
label to which a particular sample belongs). This can be
coded as letters and (or) integers. The first column of the
dataset contains a gene label ID and is used for plotting
and reporting purposes. Each subsequent entry following
the first column is a suitably normalized gene expression
Choosing groups to be used for the analysis Figure 5
Choosing groups to be used for the analysis. The brain tissue dataset where all three groups (Young, Middle and Aged) 
have been chosen.BMC Bioinformatics 2006, 7:59 http://www.biomedcentral.com/1471-2105/7/59
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measurement. There must be one row per gene, with each
column representing a measurement for the sample iden-
tified in the first row. Figures 3 and 4 show the first few
rows of an example data set (see below for more details)
in text and EXCEL formats respectively.
Illustrative example (bundled data)
The brain tissue dataset shown in Figures 3 and 4 (this will
used for all illustrations henceforth) is a microarray exper-
iment studying hippocampal aging and cognitive impair-
ment. The goal of the experiment was to look for gene
expression changes that track aging-dependent cognitive
decline. Hippocampal CA1 tissue was collected from 4,
14, and 24 month old male Fischer rats after 7 days train-
ing on a water maze which included object memory task
(see [19] for details). There were 10, 9 and 10 samples col-
lected for the respective age groups. The age groups are
labeled as Young, Middle, and Aged. The data are availa-
ble at the National Center for Biotechnology Information
(NCBI) Gene Expression Omnibus (GEO) data repository
under series record accession number GSE854. This data-
set comes pre-bundled with the default BAMarray™ instal-
lation. The default input directory (initialized when the
user first starts the software) contains the brain tissue
dataset.
Importing data
To open a microarray data set, click New under the File
menu of the BAMarray™ main console and browse for the
data. Once the file is found, click to highlight it, then click
the Open button at the bottom of the Open File dialog
box. Another dialog box will appear prompting for the
groups to be used in the analysis. Groups can be added or
removed by using the Add and Remove buttons respec-
tively. Alternatively, for data with many groups, the user
can select all groups (using SHIFT+END, or CTRL-A), or
any subset (using SHIFT_PAGEUP, SHIFT_PAGEDN,
SHIFT_ARROWUP, SHIFT_ARROWDN), instead of hav-
ing to click on each group one at a time. All "standard"
navigation keys can be used. Figure 5 shows the brain tis-
sue dataset where all three groups have been chosen. After
selecting the groups, click OK. The program will then read
the data and notify the user of progress by way of the sta-
tus bar at the bottom of the BAMarray™ main console. File
name, number of groups, number of samples per group
and total number of genes (probe sets) is provided in the
file information panel on the main console.
BAMarray™ run settings
After the data is successfully read, several different run
options can be selected from the main console (Figure 6).
Main console Figure 6
Main console. Main console. Group label "Young" is selected as the baseline for the analysis.BMC Bioinformatics 2006, 7:59 http://www.biomedcentral.com/1471-2105/7/59
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Many of these values are preset at well chosen default val-
ues and do not necessarily have to be adjusted (in fact,
users are recommended not to adjust these values until
they become familiar with the software and method).
The description of key run options are as follows :
(a) Accuracy: Low, Medium, High and Super settings cor-
respond to the number of iterations for the Gibbs sam-
pler. The Gibbs sampler is a Monte Carlo method for
estimating parameter values of interest. The more itera-
tions used (i.e., Super vs Low), the more accurate, but the
longer the run time. For data exploration, a Medium set-
ting will suffice. However, it is good practice to confirm
results at the High or Super setting when possible.
(b) Baseline: This allows the user to define the baseline
group for comparison purposes. The rationale for the
baseline group is provided in [10,12]. It is typical to assign
a control group or perhaps a normal or preliminary dis-
ease state as the baseline group. In our colon cancer exam-
ple the BSurvivors represent the baseline, whereas in the
brain tissue dataset the Young group serves as the baseline
(see Figure 6). For time-course data the zero time point
might be the most sensible baseline choice. Note that a
No Baseline option is also available; details are provided
later.
(c) Clustering:
Automatic and Manual settings. The default Automatic
setting implements a variance stabilization and regulari-
zation step that systematically removes gene specific
Cluster diagnostic plot Figure 7
Cluster diagnostic plot. Used to assess the adequacy of the variance stabilization transformation (determined using a hybrid 
CART algorithm). As the number of clusters increases, the dashed lines (attempted transformations) get closer to the thick 
line (target distribution).BMC Bioinformatics 2006, 7:59 http://www.biomedcentral.com/1471-2105/7/59
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mean-variance trends. This is important to satisfy the con-
stant variance assumption of the BAM model. The under-
lying method is based on a CART clustering approach and
has the important feature that it does not alter the original
signal to noise ratio of the data as seen with global trans-
formation, such as logarithms (Ishwaran and Papana
(2005)). Thus we recommend that users not pre-process
their data and use the clustering procedure instead to pro-
vide variance stabilized transformed data. For advanced
users a Manual option is used to pre-specify the number
of clusters. One should carefully consult Ishwaran and
Papana (2005) before experimenting with this option,
however.
(d) Variance: Equal and Unequal settings. Expression val-
ues for genes are expected to have different variances (this
is addressed by (c)). This option, however, indicates
whether the variability of expression values differs over
experimental group as well. The default Equal  option
implies equal variances across groups. Graphical diagnos-
tic plots (to be discussed shortly) are provided for assess-
ing if this assumption is met. For many applications, an
equal variance model will be reasonable. For more details
please consult [12] and Ishwaran and Papana (2005).
Clicking Run initiates the analysis. A status and progress
bar at the bottom of the BAMarray™ main console indicate
Standard deviations for genes Figure 8
Standard deviations for genes. Standard deviations for each gene after the clustering transformation for brain tissue data. 
Used to assess the equal variance assumption. Green points indicate genes which are being turned off for Aged compared to 
Young. Red indicates genes being turned on for Aged compared to Young. Blue points are genes that are not differentially 
expressing.BMC Bioinformatics 2006, 7:59 http://www.biomedcentral.com/1471-2105/7/59
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how long the Gibbs sampler will take and when the anal-
ysis has successfully completed.
BAMarray™ graphics
The graphical suite becomes available once the Gibbs
sampling step is completed. BAMarray™ graphics can be
broadly grouped into two categories: Data Plots and Infer-
ential Plots.
1. Data Plots are used to verify the assumption of equal
variances. These include (i) cluster diagnostic plots, (ii)
standard deviation plots, (iii) group mean plots, and (iv)
V-plots (the last three are based on the transformed data).
2. Inferential Plots are based on estimated parameters from
the model and are used for detecting differentially
expressing genes. These include color enhanced shrinkage
plots of Zcut values for identifying differentially express-
ing genes for a specific group. Also provided are multi-
group Zcut scatter plots (similar to Figure 1 described
earlier) for visualizing differentially expressing genes
simultaneously over two or more groups.
Data plots for assessing model assumptions: cluster 
diagnostic plots
If the Clustering option is set to Automatic, BAMarray™
presents a cluster diagnostic plot for assessing the ade-
quacy of the variance stabilization transformation. Figure
7 shows a "Cluster Diagnostic" plot. The solid blue line
represents the percentiles for the theoretical target under a
constant variance assumption. The dashed lines are values
under the attempted transformations. As the number of
V-plot Figure 9
V-plot. V-plot of the Aged versus Young comparison in the brain tissue data. The tightness of the "V" is used to assess the 
equal variance assumption. Color defined as in Figure 8.BMC Bioinformatics 2006, 7:59 http://www.biomedcentral.com/1471-2105/7/59
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clusters increases, the dashed lines will become closer to
the solid line. See Ishwaran and Papana (2005) for more
details.
Data plots for assessing model assumptions: standard 
deviation, group mean difference and v-plots
Standard deviation and group mean difference plots can
be examined to assess validity of the transformation. If an
equal variance model has been approximately achieved,
there should be no obvious trend visible in either of the
above plots (i.e., they should look like random scatter).
Figure 8 shows genewise standard deviations for groups
Aged and Young on the transformed scales. Notice the
lack of apparent structure and the relative tightness of the
data points around the value (1.0,1.0) that is the target
value.
The V-plot [12] is another tool to assess adequacy of the
equal variance transformation. If variances have stabilized
to values near 1, then plotting the group mean difference
for a gene versus the corresponding t-statistic in absolute
values (both derived using transformed data) should give
a plot with a line having constant slope. These theoretical
lines (one in each direction of group mean differences)
are overlayed as dotted black lines on the V-plot and the
tightness around this line provides a graphical indication
of the appropriateness of the transformation. See Figure 9.
Inferential plots for detecting differentially expressing 
genes: shrinkage plots
Shrinkage plots [10,12] are used to identify genes found
to be differentially expressing (either up or down) relative
to the baseline. Figure 10 is the shrinkage plot for the Zcut
Shrinkage plot Figure 10
Shrinkage plot. Shrinkage plot for determining genes differentially expressing for the "Aged" group relative to the baseline 
group 'Young". Color defined as in Figure 8.BMC Bioinformatics 2006, 7:59 http://www.biomedcentral.com/1471-2105/7/59
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gene differential effects of the Age group from the brain
tissue data (relative to the baseline group, Young). Green
points indicate genes which are being turned off for the
Aged group, whereas red indicates genes being turned on.
Blue points are genes that are not differentially expressing.
The horizontal axis for the shrinkage plot are Zcut gene
differential effects while the vertical axis are the corre-
sponding posterior variances. Theoretical arguments
show that genes that are truly differentially expressing will
have posterior variances that coalesce to 1 on the far left
and right sides of the plot. As the number of samples
increases, eventually all of the truly differentially express-
ing genes will be found and none of the non-differentially
expressing genes will be falsely detected [12]. BAMarray™
uses this principle to determine a data adaptive cutoff
value.
Inferential plots for detecting differentially expressing 
genes: multigroup scatterplots and zooming in
Figure 12 presents a Zcut multigroup scatter plot. Figure
11 shows the dialog box used to generate the plot. The
dialog box is used to select which Zcut values are plotted
on the x and y-axes respectively. In the case of more than
three groups the dialog box expands and includes an over-
lay option that allows an additional group's Zcut values to
be superimposed on the plot. Triangles indicate genes
expressing up or down for that group (recall Figure 1
where the overlay group was the Duke C's).
The legend in the top right corner of Figure 12 indicates
how each gene is mapped to a particular pattern type of
differential expression across the experimental groups. As
in the shrinkage plot, the actual decision of whether a
gene is significant and which group it belongs to is done
automatically by BAMarray™. Different colors correspond
to different expression profile types across groups. A gene
could, for example, be significantly upregulated going
from Young to Medium to Aged or down regulated going
from Young to Medium but not from Medium to Aged.
These patterns would correspond to the magenta color in
the upper right hand quadrant of Figure 12 and the green
data points hugging the negative y-axis respectively. Mul-
tigroup scatter plots are typically dense. It is often useful
to zoom in on particular genes or particular gene expres-
sion patterns to improve clarity. Figure 13 shows the las-
soing zoom-in feature available in BAMarray™. A lassoed
box focused on only those genes that are significantly
upregulated for the Aged group but not the Middle aged
group is illustrated (the so-called hit-and-run genes).
The lasso feature is activated by clicking and dragging the
mouse cursor over a region of interest. Releasing the
mouse button causes the plot to zoom in (see Figure 14).
Choosing axes for a multigroup plot Figure 11
Choosing axes for a multigroup plot. Choosing which axes to use for a Zcut multigroup plot.BMC Bioinformatics 2006, 7:59 http://www.biomedcentral.com/1471-2105/7/59
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The user can repeatedly zoom in, even examining a single
gene of interest if they choose. The original plot can
always be restored by clicking the Reset Zoom button at
the bottom of the plot. Lassoing is available on all data
and inferential plots.
Adding gene labels to plots and saving gene lists
Gene labels can be toggled on or off on almost all BAMa-
rary™ plots (Figure 15). To toggle labels, pull down the
View menu item on the plot and click on the the desired
gene subgroup. To overlay different subgroups, simply
repeat the process by clicking on a new subgroup. A word
of caution: If the zoom is reset, the original plot is restored
but the labels will still be on. This can considerably slow
the program down. However, gene labels for a particular
subgroup can always be removed by going through the
gene labeling process again and clicking the subgroup off.
Labeled (and unlabeled) genes can be saved as genes lists
and output to a text file. To save all genes on the current
plot pull down the File menu on the plot and click Save
Genes As.... To add more genes to a previously saved list,
simply use the Append Genes feature on the same menu
column. For convenience BAMarray™ makes sure that
appended lists of genes contain no duplicate gene labels.
There is also a feature that allows the user to save all sig-
nificant genes. This is found on the main console under
the File Menu as Save All Sig Genes.... In particular, for
users who are interested in a fully automated session, the
procedure is:
Multigroup Zcut plot Figure 12
Multigroup Zcut plot. Zcut values by group colored by differential expression. Colors correspond to different expression 
profile types across groups for the brain tissue analysis.BMC Bioinformatics 2006, 7:59 http://www.biomedcentral.com/1471-2105/7/59
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1. Read in the data. Select the groups for the analysis and
the baseline group. Click on Run.
2. When the analysis is complete, go to the main console
under the File Menu and click on Save All Sig Genes....
This will save all significant genes and their classification
values.
Plotting options and using the gene tracking facility
BAMarray™ plots can be customized by pulling down the
Tools menu item on any graph. This will highlight an
Options command, which when activated, will open up a
Plot Options window that highlights Preferences. Plot-
ting label and character sizes can be adjusted here. Click-
ing the Apply button activates the desired changes. The
default label and character sizes are 6 pt.
Highlighting the Tracking  button in the Plot Options
window (Figure 16) opens up a dialog box that allows the
user to manually enter gene labels. Genes can be tagged
one at a time by sequentially entering gene names and
then clicking the Add button. The gene list of interest will
then be updated and viewable in the display box above.
Genes can be deleted from this list by highlighting those
genes using the mouse and then clicking Delete. This fea-
ture can be used to track genes that make up a biological
pathway of interest. Once a gene list has been produced,
clicking Apply will cause all open plots to have genes in
Lassoing a region of interest Figure 13
Lassoing a region of interest. Lassoed box of genes upregulated significantly for the Aged group but not the Middle aged 
group.BMC Bioinformatics 2006, 7:59 http://www.biomedcentral.com/1471-2105/7/59
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the gene list highlighted in boldface and their points
enclosed in a dark circle. It can be handy sometimes to
increase the plotting label size in order to clearly see the
highlighted genes on all plots.
More on assuming equal variances across groups
As discussed earlier, BAMarray™ allows for group vari-
ances to be modeled as unequal. A tip-off that an unequal
group variance transformation is required is shown in Fig-
ure 17 which shows a model with an unequal group vari-
ance structure fit under an equal variance assumption. The
standard deviations plot shows a characteristic smearing
effect indicating that the variance clustering algorithm was
not able to achieve constant variance across genes. Con-
trast this with Figure 18 which uses the Unequal variance
clustering option that allows for unequal group variances.
Note how the smearing effect has all but vanished.
The no baseline option
There are occasions when fitting a model with a No Base-
line option is of interest. This option is accessible under
the  Tools  menu on the main console under Baseline
Options. Clicking on No Baseline Selection enables this
feature for the session. No baseline means that each gene
effect is being tested against a null value of zero (i.e. no
detectable effect at all) rather than against a defined base-
line group.
Example: tracking tumor progression genes. The colon cancer
example presented earlier compared the various stages of
colon cancer against the early onset BSurvivors group. In
an informal sense, this analysis asks the question "what
makes a good tumor go bad?" Another approach would
be to identify genes that track the stagewise progression of
metastatic colon cancer. This can be done by creating a
Lassoed region Figure 14
Lassoed region. Releasing the mouse lassoes the region of interest.BMC Bioinformatics 2006, 7:59 http://www.biomedcentral.com/1471-2105/7/59
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new response variable, which measures the difference in
gene expression between the successive stages of colon
cancer, and then using a four-group analysis with no base-
line in BAMarray™. The new response values would
include modified stage C gene expression data created by
comparing C measurements for a gene to some overall
summary measurement for the corresponding BSurvivors
gene. Similarly there would be a modified stage D meas-
urement designed to measure difference from the D's to
the C's. Finally we would have modified METS expression
values recording differences between the METS and the
D's. Each gene effect could then be tested against the null
value of zero and statistical inference would reveal which
genes have significant changes in gene expression as a
function of stagewise progression of colon cancer.
Discussion
The need for high quality software is rapidly growing in
the area of genomic research. More powerful and elegant
ways to store and analyze data are making mining the vast
quantities of data we collect much more manageable and
time efficient. Our main objective in producing BAMar-
ray™ was to provide cutting edge statistical tools embed-
ded within a sophisticated and easy-to-use graphical
interface. Our goal was to free the user from as many sub-
jective choices as possible and facilitate interactions with
their data. While some knowledge of the underlying
methodology is certainly useful, our main focus was to
delineate the methodological ideas via simple, yet elegant,
graphics that would make the software much more
approachable for non-statisticians. Yet because the output
Adding gene label IDs Figure 15
Adding gene label IDs. Gene labels can be added to almost any plot. Labels are toggled using the View menu item.BMC Bioinformatics 2006, 7:59 http://www.biomedcentral.com/1471-2105/7/59
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from our software is stored in text format with clean and
simple summary structures, it makes it possible for a more
advanced statistical user to interface BAMarray™ with their
own favorite products.
BAMarray™ has some key advantages which can be sum-
marized and contrasted against other similar software.
These include:
1. BAMarray is a stand-alone desktop Java application that
interfaces with a native code C library. The software is
highly portable and it is possible to create builds of the
software for virtually any operating system. At this time,
the software has solutions for the Mac OS X (10.3+),
Linux, and the Windows XP operating systems.
2. BAMarray™ allows for a full multigroup analysis. This
facilitates the searching for complex biological patterns
such as the hit-and-run patterns of differential expression
described earlier in this manuscript. Of course, many
other applications are possible. For example, the very
large number of experimental groups that can be analyzed
(up to 256) facilitates studying expression changes in data
settings where group labels could be tissue types collected
from multiple regions within an organism (for human
data this could be used for a genomic body map analysis
for example).
3. BAMarray™ is nearly automatic in its usage. The user is
freed from having to set and (or) choose tuning parame-
ters, many of which can often affect the resulting conclu-
Tracking specific genes of interest Figure 16
Tracking specific genes of interest. Genes can be tagged one at a time by sequentially entering gene names using the 
Tracking button in the Plot Options dialog box.BMC Bioinformatics 2006, 7:59 http://www.biomedcentral.com/1471-2105/7/59
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sions [20]. Instead, we appeal to underlying theory to set
tuning parameters at theoretically optimal values.
4. BAMarray™ importantly does not require a user-speci-
fied cutoff value for identifying significant genes. This is
often the most difficult part of using a statistical software
package. The choice of what is deemed significant is often
arbitrary and dictated by available resources for follow-up
analyses. Instead with BAMarray™, the cutoff values are set
by appealing to the underlying theory via a novel shrink-
age plot. From this plot, genes with posterior variances
coalescing at a value of 1 are guaranteed to be truly differ-
entially expressing with probability tending to 1.
5. Unequal variances across genes and (or) experimental
groups is a common occurrence in multigroup studies. As
described, global variance stabilizing transformations can
be difficult to find and also unduly affect signal-to-noise
ratios. BAMarray™ uses a sophisticated local variance sta-
bilizing CART algorithm which does not suffer from the
adverse properties of a global transformation. Impor-
tantly, this type of variance stabilization can also be used
as a pre-processing step on its own. So even if a user would
eventually like to analyze data in another package, vari-
ance stabilization can still be handled effectively in
BAMarray™.
6. A no-baseline option in BAMarray™ allows for some
non-standard experimental designs to be analyzed. This
includes analyzing one-way ANOVA models (for example
paired experimental designs), time course gene expression
profiles, or perhaps tracking disease progression genes.
Standard deviations assuming equal variances Figure 17
Standard deviations assuming equal variances. Data analyzed by assuming equal variances across groups. Note the smear 
effect that is typical of a violation of the equal variance assumption.BMC Bioinformatics 2006, 7:59 http://www.biomedcentral.com/1471-2105/7/59
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7. A suite of graphical tools are available in BAMarray™.
These include diagnostic plots to check for the appropri-
ateness of model assumptions and the adequacy of the
pre-processing; zoom-in and lassoing features that allow
the user to interactively generate lists of differentially
expressing genes; toggling on or off of gene labels; and a
gene tracker function that allows pre-specified lists of
genes to be interactively tracked for differential expression
across experimental groups.
8. Gene lists can exported to any software package that can
read simple text files. A myriad of possibilities exist for fol-
low-up analyses, but for most users, annotating gene lists
would be of first importance. This can be done easily by
importing significant gene lists from BAMarray™ into
packages like GeneSpring, NetAffx™ or Bioconductor.
9. All figures can be saved as publication quality color
graphics.
10. Analyses can be done at various levels of accuracy. This
amounts to user-control over how many Gibbs sampling
iterations are allowed. For most exploratory, first-wave
analyses, a lower number of iterations would be sufficient.
When conducting confirmatory analyses, a much larger
number of iterations can be set.
What's next?
Our illustrative example involving colon cancer showed
how BAMarray™ can be used to track differentially
expressing genes in multigroup experiments by statisti-
cally mapping genes to unique differential expression pat-
tern types (for example, hit-and-run patterns). An
Standard deviations assuming unequal variances Figure 18
Standard deviations assuming unequal variances. Data analyzed by assuming variances are unequal across groups. Note 
the lack of smearing indicating a better fit.BMC Bioinformatics 2006, 7:59 http://www.biomedcentral.com/1471-2105/7/59
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important outcome of this is the ability to group genes by
pattern type in order to find more focused underlying
biology. We note, however, that higher order analyses like
building molecular classifiers or survival outcome predic-
tors can also benefit from this information. In fact, the
very patterns that are found can be used in a special way
to help build more powerful molecular models. This is
work that we will report on shortly.
In addition to this work, the team continues to upgrade
the software and a new release, Release 3.0, will soon be
made available at http://www.bamarray.com. This major
upgrade will contain some important enhancements to
the product. For example, the capability to run BAMar-
ray™ in an unattended Batch Mode initiated from a script
file will be available. Batch Mode allows users to source
BAMarray™ from any application that implements the use
of operating system command driven script files. Writing
custom designed scripts allow users to interface with dif-
ferent types of software, such as Bioconductor, and R, and
could be used, for example, to automate the process of
normalizing data. Release 3.0 will also have a Save Run
feature allowing users to save the results of a run for later
retrieval. A run that can take minutes to execute can be
restored in only seconds using a Restore Run feature. Save
Run can also be triggered in Batch Mode. This unique fea-
ture allows users to batch multiple jobs for later retrieval.
Finally, Release 3.0 will allow users to populate a tracking
list from gene labels found in an existing file. These and
many more enhancements will be found in the next
release of the product.
Conclusion
BAMarray™ is user friendly Java-based software that effec-
tively and efficiently implements the BAM methodology
for analyzing expression data from multigroup experi-
mental designs. The portability and flexibility of the prod-
uct make it possible to rapidly adapt BAMarray™ to the
highly dynamic field of genomic informatics and to mod-
ify the existing product to allow for seemless interface
with other software and data mining tools as they become
available.
Availability and requirements
1. Project name: BAM
2. Project home page: http://www.bamarray.com
3. Operating system(s): Windows XP, Linux, Mac OS X
(10.3+).
4. Programming language: Java, C.
5. Other requirements: 512 MB RAM, 2.0 GHz Pentium 4
CPU, 200 MB free disk space on hard drive, Sun Java™ 2
Runtime Environment, Standard Edition (JRE) 1.4X. For
Windows XP, installation must be done by users in the
"Administrators" group or "Power Users" group only.
6. License: Academic and commercial license available
from Technology Transfer Office at Case Western Reserve
University. Details found at http://www.bamarray.com.
7. Any restrictions to use by non-academics: License
needed.
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